BioSpace News Archive

Basilea Pharmaceutica Ltd announced the unaudited preliminary revenues for the financial year 2022 and provided an update on the progress made with its commercial brands Cresemba® and Zevtera®, as well as in advancing its R&D portfolio in 2022.

Safe, a company specializing in the design, manufacturing and marketing of ready-to-use technologies for orthopedic surgeries, especially for back surgery, announces its 2022 annual revenue and its cash position.

LEX Diagnostics announces the appointment of Ed Farrell as its new Chief Executive Officer.

Medivir AB announced that its partner Infex Therapeutics, a leading anti-infectives specialist, has been granted Qualified Infectious Disease Product designation for MET-X by the U.S. Food and Drug Administration.

MTF Biologics, a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, transplantation, and research, has awarded more than $850,000 in funding to seven researchers across the nation through its 2022 Extramural Research Grants Program.

BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTC Pink: BMKDF) (“BioMark” or the “Company”) an advanced stage liquid biopsy company with a focus on hard to detect and treat cancers is pleased to announce several updates from ongoing clinical trial using the Company’s liquid biopsy test for early cancer detection and monitoring of lung cancer.

As a trusted provider of high-quality isolated human stem and immune cells for over a decade, StemExpress is now proud to offer select isolated products in bulk through their CellsExpress service.

Pheno Therapeutics Limited., a biotechnology company focused on the discovery and development of small molecule therapeutics that promote remyelination for the treatment of neurological diseases such as multiple sclerosis, announced today it has entered into an exclusive worldwide license agreement with UCB.

Athersys, Inc. (NASDAQ: ATHX) announced today their participation in two January conferences, Advanced Therapies Week presented by Phacilitate from January 17-20, 2023 in Miami, FL and the 2nd Allogeneic Cell Therapies Summit Europe from January 30-February 1, 2023 in London, UK.

Ariadne Labs announced five recipients of the Ariadne Labs Spark Grant innovation awards for the 2022-2023 year.